SCHMID JOHN P. purchased 69.2% of their position (4.50K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market purchase worth $9.7K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/14/2024ACC: 0001867096-24-000034
Director
Since Oct 2021
+4.50K
Net shares
Net buyer
$9.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.50K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+4.50K
Price / share
$2.16
Trade value
$9.72K
% of position
69.2%
3/14/2024
6.50K→11K
Total
Net shares
+4.50K
Net value
$9.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/14/2024 | P · Purchase | +4.50K | $2.16 | $9.72K | 69.2% | 6.50K | 11K |
| Total | +4.50K | $9.72K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned63.16K
Total
63.16K direct63.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 63.16K | Direct |
| Total | 63.16K | 63.16K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported